Skip to main content
Equibles
AMRN logo

AMRN · Amarin Corp Plcuk · Metrics

Track AMRN — free

Use AMRN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AMRN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.32 +0.27 (+2.25%) Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$506.61M
Shares
42.04M
Volume · Nov 4 33.45K Avg daily vol (3M) 69.27K

AMRN metrics

79 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.05
Market cap
$506.61M

Price action

20 metrics
Price change (1W)
+0.3%
Price change (30D)
+0.3%
Price change (3M)
-14.2%
Price change (6M)
-14.8%
Price change (YTD)
-13.1%
Price change (1Y)
-25.5%
Trailing year
Price change (5Y)
—
52-week high
$16.98
52-week low
$11.32
Change from 52-week high
-28.6%
Change from 52-week low
+7.2%
Annualized volatility
40.8%
Annualized volatility (3M)
28.8%
Beta
0.4
RSI (14D)
47.0
Price vs SMA 50
-6.2%
Price vs SMA 200
-15.2%
Avg volume (3M)
69,154
Relative volume
1.5
Average dollar volume
$913,857

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
42.04M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.9×
reciprocal yield 34.5%
P / book
1.1
reciprocal yield 87.1%
FCF yield
—
TTM · current market cap
Buyback yield
0.2%
P / FCF
—
P / operating cash flow
13.6
reciprocal yield 7.4%
Earnings yield
-3.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.2%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-28

Profitability

9 metrics
Gross margin
40.9%
Operating margin
-18.2%
Trailing 12 months
Net margin
-10.9%
Gross profit (TTM)
$72.11M
Operating profit (TTM)
−$32.03M
Net income (TTM)
−$19.14M
Trailing 12 months
Diluted EPS (TTM)
$-0.05
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.42
Gross profit per diluted share (TTM)
$0.17
Operating profit per diluted share (TTM)
$-0.08
EBITDA per diluted share (TTM)
$-5.06
Net income per diluted share (TTM)
$-0.05
Operating cash flow per diluted share (TTM)
$0.09
Free cash flow per diluted share (TTM)
$-1.18
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.05
Stock compensation per diluted share (TTM)
$0.02
Book value per share
$1.05

Growth

11 metrics
Revenue growth YoY
-20.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$176.11M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.0%
Year over year · more shares
Revenue CAGR (3Y)
-16.7%
Revenue CAGR (5Y)
-19.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-4.3%
Return on assets
-3.0%
Debt / equity
—
Current ratio
3.5
EBITDA (TTM)
−$79.25M
Free cash flow (TTM)
—
Quick ratio
2.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$156.51M
Total assets
$634.08M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$37.49M
Capital expenditures (TTM)
$252,000
R&D (TTM)
$19.01M
SG&A (TTM)
$77.70M
Stock compensation (TTM)
$7.42M
R&D / revenue
10.8%
Stock compensation / revenue
4.2%

Ownership (13F)

9 metrics
13F filers
81
13F filer change QoQ
+11
Institutional ownership
11.2%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.2%
Holder tenure
15.8
Price vs estimated holder cost
-31.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.1%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 7.3 days to cover
Days to cover
7.3d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 897448 CUSIP 023111404 13F (30d) 26 filings 20 filers Visit website Investor relations